Bruce Shiramizu to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications Bruce Shiramizu has written about Lymphoma, Non-Hodgkin.
Connection Strength
1.518
-
Shiramizu B, Mussolin L, Woessmann W, Klapper W. Paediatric non-Hodgkin lymphoma - perspectives in translational biology. Br J Haematol. 2016 05; 173(4):617-24.
Score: 0.536
-
Kusao I, Agsalda M, Troelstrup D, Villanueva N, Shiramizu B. Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease. Pediatr Blood Cancer. 2008 Aug; 51(2):193-7.
Score: 0.315
-
Killebrew D, Shiramizu B. Pathogenesis of HIV-associated non-Hodgkin lymphoma. Curr HIV Res. 2004 Jul; 2(3):215-21.
Score: 0.238
-
Sabesan V, Cairo MS, Lones MA, Perkins SL, Morris E, Sposto R, Van De Ven C, Shiramizu B. Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers. J Pediatr Hematol Oncol. 2003 Feb; 25(2):109-13.
Score: 0.215
-
Shiramizu B, McGrath MS. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 1991 Apr; 5(2):323-30.
Score: 0.095
-
Magrath IT, Shiramizu B. Biology and treatment of small non-cleaved cell lymphoma. Oncology (Williston Park). 1989 Nov; 3(11):41-53; discussion 53-4, 56, 59-60.
Score: 0.086
-
Herndier BG, Shiramizu BT, McGrath MS. AIDS associated non-Hodgkin's lymphomas represent a broad spectrum of monoclonal and polyclonal lymphoproliferative processes. Curr Top Microbiol Immunol. 1992; 182:385-94.
Score: 0.025
-
Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, Volberding PA, McGrath MS. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood. 1995 Apr 01; 85(7):1727-35.
Score: 0.008